Landscapes / Targets
CD28
9 drugs act on CD28, in 15 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs9
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Johnson & Johnson (Janssen) · Public JNJ |
Phase 3 | 18 Aug 2028Phase 3 trial completes | ||
| Next date | 18 Aug 2028 · Phase 3 trial completes | ||||
| Also tested for | Prostatic Neoplasms, Metastatic Castration-resistant Prostatic Neoplasms | ||||
| Open drug page | |||||
Multi-specific immunoglobulin |
Regeneron · Public REGN |
Phase 1/2 | 15 Nov 2027Phase 1/2 trial completes | ||
| How it works | An antibody built to latch onto two or more targets at once | ||||
| Next date | 15 Nov 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC) and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Aug 2028Phase 1/2 trial completes | |||
| Next date | Aug 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Biliary Tract Cancer, Breast Cancer and 19 more | ||||
| Open drug page | |||||
— |
Regeneron · Public REGN |
Phase 1/2 | 8 Nov 2028Phase 1/2 trial completes | ||
| Next date | 8 Nov 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Ovarian Cancer, Fallopian Tube Cancer and 2 more | ||||
| Open drug page | |||||
Multi-specific immunoglobulin |
Regeneron · Public REGN |
Phase 2 | 4 Dec 2029Phase 2 trial completes | ||
| How it works | An antibody built to latch onto two or more targets at once | ||||
| Next date | 4 Dec 2029 · Phase 2 trial completes | ||||
| Also tested for | Non Small Cell Lung Cancer, Advanced Solid Tumors and 4 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2028Phase 1 trial completes | |||
| Next date | Dec 2028 · Phase 1 trial completes | ||||
| Also tested for | Ovarian Cancer | ||||
| Open drug page | |||||
— |
Regeneron · Public REGN |
Phase 1 | 16 Feb 2029Phase 1 trial completes | ||
| Next date | 16 Feb 2029 · Phase 1 trial completes | ||||
| Also tested for | B-cell Non-Hodgkins Lymphoma (B-NHL) | ||||
| Open drug page | |||||
— |
Phase 1 | 28 Feb 2029Phase 1 trial completes | |||
| Next date | 28 Feb 2029 · Phase 1 trial completes | ||||
| Also tested for | Non Small Cell Lung Cancer, Cervical Cancer and 8 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 9 of 9 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026